{"database": "openregs", "table": "federal_register", "rows": [["2011-5144", "Oral Dosage Form New Animal Drugs; Spinosad and Milbemycin Oxime", "Rule", "The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Elanco Animal Health. The NADA provides for veterinary prescription use of chewable tablets containing spinosad and milbemycin oxime in dogs for the treatment and prevention of flea infestations and for the prevention and control of various internal parasites.", "2011-03-08", 2011, 3, "https://www.federalregister.gov/documents/2011/03/08/2011-5144/oral-dosage-form-new-animal-drugs-spinosad-and-milbemycin-oxime", "https://www.govinfo.gov/content/pkg/FR-2011-03-08/pdf/2011-5144.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Elanco Animal Health. The NADA provides for veterinary prescription use of chewable tablets containing...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2011-5144"], "units": {}, "query_ms": 0.5994520615786314, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}